Taysha Gene Therapies, Inc.
TSHA
9 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Jan 24 12:59 AM | Sean McAuliffe | Proposed Sale | 46,064 | $5.09 | $234.5K | — | View → |
| Jan 23, 2026 | Jan 24 12:58 AM | Kamran Alam | Proposed Sale | 100,846 | $5.09 | $513.3K | — | View → |
| Jan 12, 2026 | Jan 12 9:19 PM | Nagendran Sukumar | Proposed Sale | 200,000 | $4.98 | $996.0K | — | View → |
| Nov 28, 2025 | Nov 28 6:07 PM | Nagendran Sukumar | Proposed Sale | 370,172 | $4.86 | $1.8M | — | View → |
| Sep 22, 2025 | Sep 22 11:18 PM | Rumana Haque-Ahmed | Proposed Sale | 10,770 | $2.83 | $30.5K | — | View → |
| Sep 10, 2025 | Sep 10 8:28 PM | Nagendran Sukumar | Proposed Sale | 200,000 | $3.26 | $652.0K | — | View → |
| Aug 21, 2025 | Aug 22 1:12 AM | Kamran Alam | Proposed Sale | 54,491 | $2.87 | $156.4K | — | View → |
| Aug 21, 2025 | Aug 22 1:11 AM | Emily McGinnis | Proposed Sale | 19,604 | $2.87 | $56.3K | — | View → |
| Aug 21, 2025 | Aug 22 1:10 AM | Sukumar Nagendran | Proposed Sale | 57,054 | $2.87 | $163.7K | — | View → |
| Aug 21, 2025 | Aug 22 1:09 AM | Sean McAuliffe | Proposed Sale | 27,590 | $2.87 | $79.2K | — | View → |
| Aug 21, 2025 | Aug 22 1:08 AM | Fred Porter | Proposed Sale | 50,451 | $2.87 | $144.8K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2 8:30 PM | John A Stalfort IIIDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Phillip B. DonenbergDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Alison S LongDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Laura Sepp-LorenzinoDirector | Grant/Award | 42,671 | $5.97 | 42,671(D) | View → |
| Apr 10, 2026 | Apr 13 8:33 PM | Sukumar NagendranDirector, President and Head of R&D | Option Exercise | 19,021 | $1.71 | 455,920(D) | View → |